Connection

Fengcai Zhu to Hepatitis E

Back to Details
This is a "connection" page, showing publications Fengcai Zhu has written about Hepatitis E.
Fengcai Zhu
Connection Strength
0.123
Hepatitis E
  1. A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine. Vaccine. 2017 09 05; 35(37):5073-5080.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.